fCare: Press Release: Dupixent® FDA approved as first and only treatment indicated for children aged 1 year and older with eosinophilic esophagitis (EoE)

Press Release: Dupixent® FDA approved as first and only treatment indicated for children aged 1 year and older with eosinophilic esophagitis (EoE)

https://ift.tt/Aqzhbya

from Sanofi - Aventis Groupe https://ift.tt/PQMzayZ
via IFTTT

from health care https://ift.tt/VgIh4NE
via IFTTT https://ift.tt/XF4mQnI

fCare

Pages

Press Release: Dupixent® FDA approved as first and only treatment indicated for children aged 1 year and older with eosinophilic esophagitis (EoE)

No comments:

Post a Comment